- Home
- SCWO vs CVKD Comparison
SCWO vs CVKD Comparison
Compare SCWO & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCWO
- CVKD
- Stock Information
- Founded
- SCWO 2021
- CVKD 2022
- Country
- SCWO United States
- CVKD United States
- Employees
- SCWO N/A
- CVKD N/A
- Industry
- SCWO Environmental Services
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- SCWO Utilities
- CVKD Health Care
- Exchange
- SCWO Nasdaq
- CVKD Nasdaq
- Market Cap
- SCWO 39.9M
- CVKD 33.7M
- IPO Year
- SCWO N/A
- CVKD 2023
- Fundamental
- Price
- SCWO $0.32
- CVKD $15.50
- Analyst Decision
- SCWO
- CVKD Strong Buy
- Analyst Count
- SCWO 0
- CVKD 1
- Target Price
- SCWO N/A
- CVKD $32.00
- AVG Volume (30 Days)
- SCWO 170.6K
- CVKD 21.0K
- Earning Date
- SCWO 05-15-2025
- CVKD 05-08-2025
- Dividend Yield
- SCWO N/A
- CVKD N/A
- EPS Growth
- SCWO N/A
- CVKD N/A
- EPS
- SCWO N/A
- CVKD N/A
- Revenue
- SCWO $445,445.00
- CVKD N/A
- Revenue This Year
- SCWO $5,945.19
- CVKD N/A
- Revenue Next Year
- SCWO $106.82
- CVKD N/A
- P/E Ratio
- SCWO N/A
- CVKD N/A
- Revenue Growth
- SCWO N/A
- CVKD N/A
- 52 Week Low
- SCWO $0.25
- CVKD $5.70
- 52 Week High
- SCWO $1.99
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- SCWO 54.08
- CVKD 41.03
- Support Level
- SCWO $0.26
- CVKD $15.29
- Resistance Level
- SCWO $0.29
- CVKD $17.00
- Average True Range (ATR)
- SCWO 0.03
- CVKD 0.80
- MACD
- SCWO 0.01
- CVKD -0.02
- Stochastic Oscillator
- SCWO 70.00
- CVKD 9.50
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.